These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 8794442)

  • 21. A double-blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms.
    Hammar M; Christau S; Nathorst-Böös J; Rud T; Garre K
    Br J Obstet Gynaecol; 1998 Aug; 105(8):904-11. PubMed ID: 9746385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endometrial response in estrogen replacement therapy quarterly combined with a progestogen.
    Boerrigter PJ; van de Weijer PH; Baak JP; Fox H; Haspels AA; Kenemans P
    Maturitas; 1996 May; 24(1-2):63-71. PubMed ID: 8794436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 17 beta-estradiol and norethisterone acetate in low doses as continuous combined hormone replacement therapy.
    Stadberg E; Mattsson LA; Uvebrant M
    Maturitas; 1996 Feb; 23(1):31-9. PubMed ID: 8861084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of continuous combined transdermal oestrogen-progestogen treatment on bleeding patterns and the endometrium in postmenopausal women.
    Oosterbaan HP; van Buuren AH; Schram JH; van Kempen PJ; Ubachs JM; van Leusden HA; Beyer GP
    Maturitas; 1995 Apr; 21(3):211-9. PubMed ID: 7616870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. One-year randomized study of the endometrial safety and bleeding pattern of 0.25 mg drospirenone/0.5 mg 17β-estradiol in postmenopausal women.
    Genazzani AR; Schmelter T; Schaefers M; Gerlinger C; Gude K
    Climacteric; 2013 Aug; 16(4):490-8. PubMed ID: 23531117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endometrial effects of transdermal estradiol/norethisterone acetate.
    Lindgren R; Risberg B; Hammar M; Berg G; Pryse-Davies J
    Maturitas; 1992 Aug; 15(1):71-8. PubMed ID: 1528133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of a triphasic oestradiol/norethisterone acetate preparation with and without an oestriol component in the treatment of climacteric complaints.
    Hellberg D; Nilsson S
    Maturitas; 1984 Apr; 5(4):233-43. PubMed ID: 6429481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
    Yildirim G; Tugrul S; Uslu H; Pekin O; Eren S
    Arch Gynecol Obstet; 2006 Feb; 273(5):268-73. PubMed ID: 16315025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
    Rozenberg S; Ylikorkala O; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Norethindrone acetate and estradiol-induced endometrial hyperplasia.
    Kurman RJ; Félix JC; Archer DF; Nanavati N; Arce J; Moyer DL
    Obstet Gynecol; 2000 Sep; 96(3):373-9. PubMed ID: 10960628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy.
    Sturdee DW; Ulrich LG; Barlow DH; Wells M; Campbell MJ; Vessey MP; Nielsen B; Anderson MC; Bragg AJ
    BJOG; 2000 Nov; 107(11):1392-400. PubMed ID: 11117768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of a monophasic continuous estro-progestogenic treatment on Latin American menopausal women.
    Bassol S; Carranza-Lira S; Celis-Gonzalez C; Santoyo S; Murillo A; Martinez N; Santos J; Llaca V; de la Loza FR; Zarain J; da Fonseca AM; Camargos AF; Baracat EC; da Sá MF; Bayo J; Adaro L; Gurucharri C; Murga M; Siseles N; Sayegh F; Tempone A; Tempone LM; Tozzini RI; Boccanera R; Naranjo C; Sanchez F; Gomez G; Blanco S; Reyes-Marquez R; Albrecht G; Rios PC
    Maturitas; 2005 Mar; 50(3):189-95. PubMed ID: 15734600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spacing-out of progestin--efficacy, tolerability and compliance of two regimens for hormonal replacement in the late postmenopause.
    Rabe T; Mueck AO; Deuringer FU; Vladescú E; Runnebaum B
    Gynecol Endocrinol; 1997 Dec; 11(6):383-92. PubMed ID: 9476087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultra-low-dose continuous combined estradiol and norethisterone acetate: improved bleeding profile in postmenopausal women.
    Sturdee DW; Archer DF; Rakov V; Lang E;
    Climacteric; 2008 Feb; 11(1):63-73. PubMed ID: 18202966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of low-dose transdermal E2/NETA on the reduction of postmenopausal bone loss in women.
    Rubinacci A; Peruzzi E; Modena AB; Zanardi E; Andrei B; De Leo V; Pansini FS; Quebe-Fehling E; de Palacios PI
    Menopause; 2003; 10(3):241-9. PubMed ID: 12792297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopause.
    Notelovitz M; Cassel D; Hille D; Furst KW; Dain MP; VandePol C; Skarinsky D
    Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):7-12. PubMed ID: 10649149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of oral continuous 17beta-estradiol plus norethisterone acetate replacement therapy on abdominal subcutaneous fat, serum leptin levels and body composition.
    Yüksel H; Odabaşi AR; Demircan S; Karul A; Kozaci LD; Köseoğlu K; Kizilkaya K; Başak O
    Gynecol Endocrinol; 2006 Jul; 22(7):381-7. PubMed ID: 16864148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intermittent progestin administration as part of hormone replacement therapy: long-term comparison between estradiol 1 mg combined with intermittent norgestimate and estradiol 2 mg combined with constant norethisterone acetate.
    Ylikorkala O; Wahlström T; Caubel P; Lane R
    Acta Obstet Gynecol Scand; 2002 Jul; 81(7):654-60. PubMed ID: 12190841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaginal bleeding in postmenopausal women taking low-dose norethindrone acetate and ethinyl estradiol combinations. The FemHRT Study Investigators.
    Symons J; Kempfert N; Speroff L
    Obstet Gynecol; 2000 Sep; 96(3):366-72. PubMed ID: 10960627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal tolerability of ultra-low-dose continuous combined 17beta-estradiol and norethisterone acetate: laboratory and safety results.
    Samsioe G; Hruska J;
    Climacteric; 2010 Feb; 13(1):34-44. PubMed ID: 20001563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.